Your browser doesn't support javascript.
loading
Single fraction high-dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: toxicities and early outcomes from a single institutional experience.
Barnes, Justin M; Gabani, Prashant; Sanders, Max; Chundury, Anupama; Altman, Michael; Garcia-Ramirez, Jose; Li, Harold; Zoberi, Jacqueline E; Baumann, Brian C; Gay, Hiram A.
Afiliação
  • Barnes JM; Saint Louis University School of Medicine, Saint Louis, United States.
  • Gabani P; Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, United States.
  • Sanders M; University of Missouri-St. Louis, Saint Louis, United States.
  • Chundury A; Department of Radiation Oncology, Rutgers Robert Wood Johnson Medical School, New Brunswick, United States.
  • Altman M; Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, United States.
  • Garcia-Ramirez J; Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, United States.
  • Li H; Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, United States.
  • Zoberi JE; Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, United States.
  • Baumann BC; Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, United States.
  • Gay HA; Department of Radiation Oncology, Washington University School of Medicine, Saint Louis, United States.
J Contemp Brachytherapy ; 11(5): 399-408, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31749847

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article